-
1
-
-
0027953703
-
Insulin action, diabetogenes, and the cause of type II diabetes
-
Kahn C.R. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes. 43:1994;1066-1084.
-
(1994)
Diabetes
, vol.43
, pp. 1066-1084
-
-
Kahn, C.R.1
-
3
-
-
0023686358
-
Distribution of the murine plasma cell antigen PC-1 in non-lymphoid tissue
-
Harahap A.R., Goding J.W. Distribution of the murine plasma cell antigen PC-1 in non-lymphoid tissue. J. Immunol. 141:1988;2317-2320.
-
(1988)
J. Immunol.
, vol.141
, pp. 2317-2320
-
-
Harahap, A.R.1
Goding, J.W.2
-
4
-
-
0027944567
-
Molecular cloning expression and localization of a brain-specific phosphodiesterase I/nucleotide pyrophosphatase (PD-I alfa) from rat brain
-
Narita M., Goji J., Nakamura H., Sanak A. Molecular cloning expression and localization of a brain-specific phosphodiesterase I/nucleotide pyrophosphatase (PD-I alfa) from rat brain. J. Biol. Chem. 269:1994;28235-28242.
-
(1994)
J. Biol. Chem.
, vol.269
, pp. 28235-28242
-
-
Narita, M.1
Goji, J.2
Nakamura, H.3
Sanak, A.4
-
5
-
-
0028795761
-
Membrane glycoprotein PC1 and insulin resistance in non-insulin-dependent diabetes mellitus
-
Maddux B.A., Sbraccia P., Kumakura S. et al. Membrane glycoprotein PC1 and insulin resistance in non-insulin-dependent diabetes mellitus. Nature. 373:1995;448-451.
-
(1995)
Nature
, vol.373
, pp. 448-451
-
-
Maddux, B.A.1
Sbraccia, P.2
Kumakura, S.3
-
6
-
-
0030444778
-
Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity
-
Belfiore A., Costantino A., Frasca F. et al. Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity. Mol. Endocrinol. 10:1996;1318-1326.
-
(1996)
Mol. Endocrinol.
, vol.10
, pp. 1318-1326
-
-
Belfiore, A.1
Costantino, A.2
Frasca, F.3
-
7
-
-
0025981283
-
Production of inhibitor of insulin-receptor tyrosine kinase in fibroblasts from patient with insulin resistance and NIDDM
-
Sbraccia P., Goodman P.A., Maddux B.A. et al. Production of inhibitor of insulin-receptor tyrosine kinase in fibroblasts from patient with insulin resistance and NIDDM. Diabetes. 40:1996;295-299.
-
(1996)
Diabetes
, vol.40
, pp. 295-299
-
-
Sbraccia, P.1
Goodman, P.A.2
Maddux, B.A.3
-
8
-
-
0027265992
-
Inhibitors of insulin receptor tyrosine kinase in fibroblasts from diverse patients with impaired insulin action: Evidence for a novel mechanism of postreceptor insulin resistance
-
Maddux B.A., Sbraccia P., Reaven G.M., Moller D.E., Goldfine I.D. Inhibitors of insulin receptor tyrosine kinase in fibroblasts from diverse patients with impaired insulin action: evidence for a novel mechanism of postreceptor insulin resistance. J. Clin. Endocrinol. Metab. 77:1993;73-79.
-
(1993)
J. Clin. Endocrinol. Metab.
, vol.77
, pp. 73-79
-
-
Maddux, B.A.1
Sbraccia, P.2
Reaven, G.M.3
Moller, D.E.4
Goldfine, I.D.5
-
9
-
-
0018520840
-
Glucose clamp technique: A method for quantifying insulin secretion and resistance
-
DeFronzo R.A., Tobin J.D., Andres R. et al. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237:1979;E214-E223.
-
(1979)
Am. J. Physiol.
, vol.237
-
-
Defronzo, R.A.1
Tobin, J.D.2
Andres, R.3
-
10
-
-
0021106566
-
New concepts in the pathogenesis and treatment of non-insulin-dependent diabetes mellitus
-
DeFronzo R.A., Ferrannini E., Koivisto V. et al. New concepts in the pathogenesis and treatment of non-insulin-dependent diabetes mellitus. Am. J. Med. 74:1983;52-81.
-
(1983)
Am. J. Med.
, vol.74
, pp. 52-81
-
-
Defronzo, R.A.1
Ferrannini, E.2
Koivisto, V.3
-
11
-
-
0344914591
-
Mechanism of insulin resistance in non-insulin-dependent (type II) diabetes
-
Olefsky J.M., Ciaraldi T.P., Kolterman O.G. et al. Mechanism of insulin resistance in non-insulin-dependent (type II) diabetes. Am. J. Med. 75:1985;23-31.
-
(1985)
Am. J. Med.
, vol.75
, pp. 23-31
-
-
Olefsky, J.M.1
Ciaraldi, T.P.2
Kolterman, O.G.3
-
12
-
-
0029759418
-
PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: Relationship to insulin receptor tyrosine kinase and whole body insulin sensitivity
-
Frittitta F., Youngren J.F., Vigneri R., Maddux B.A., Trischitta V., Goldfine I.D. PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: relationship to insulin receptor tyrosine kinase and whole body insulin sensitivity. Diabetologia. 39:1996;1190-1195.
-
(1996)
Diabetologia
, vol.39
, pp. 1190-1195
-
-
Frittitta, F.1
Youngren, J.F.2
Vigneri, R.3
Maddux, B.A.4
Trischitta, V.5
Goldfine, I.D.6
-
13
-
-
0029742448
-
Skeletal muscle content of membrane glycoprotein PC-1 in obesity
-
Youngren J.F., Maddux B.A., Sasson S. et al. Skeletal muscle content of membrane glycoprotein PC-1 in obesity. Diabetes. 45:1996;1324-1328.
-
(1996)
Diabetes
, vol.45
, pp. 1324-1328
-
-
Youngren, J.F.1
Maddux, B.A.2
Sasson, S.3
-
14
-
-
0031026510
-
Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-alfa gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity
-
Frittitta L., Youngren J.F., Sbraccia P. et al. Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-alfa gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity. Diabetologia. 40:1997;282-289.
-
(1997)
Diabetologia
, vol.40
, pp. 282-289
-
-
Frittitta, L.1
Youngren, J.F.2
Sbraccia, P.3
-
15
-
-
0024347501
-
Insulin receptor kinase defects in insulin-resistant tissues and their role in the pathogenesis of NIDDM
-
Haring H., Obermaier-Kusser B. Insulin receptor kinase defects in insulin-resistant tissues and their role in the pathogenesis of NIDDM. Diabetes Metab. Rev. 5:1989;431-441.
-
(1989)
Diabetes Metab. Rev.
, vol.5
, pp. 431-441
-
-
Haring, H.1
Obermaier-Kusser, B.2
-
16
-
-
0031747108
-
Elevated PC-1 content in cultured skin fibroblasts correlates with decreased in vivo and in vitro insulin action in non-diabetic subjects: Evidence that PC-1 may be an intrinsic factor in impaired insulin receptor signalling
-
Frittitta L., Spampinato D., Solini A. et al. Elevated PC-1 content in cultured skin fibroblasts correlates with decreased in vivo and in vitro insulin action in non-diabetic subjects: evidence that PC-1 may be an intrinsic factor in impaired insulin receptor signalling. Diabetes. 47:1998;1095-1100.
-
(1998)
Diabetes
, vol.47
, pp. 1095-1100
-
-
Frittitta, L.1
Spampinato, D.2
Solini, A.3
-
17
-
-
0020382707
-
Structure of the murine plasma cell alloantigen PC-1: Comparison with the receptor for transferrin
-
Goding J.W., Shen F.W. Structure of the murine plasma cell alloantigen PC-1: comparison with the receptor for transferrin. J. Immunol. 129:1982;2636-2640.
-
(1982)
J. Immunol.
, vol.129
, pp. 2636-2640
-
-
Goding, J.W.1
Shen, F.W.2
-
18
-
-
0023255927
-
Plasma cell membrane glycoprotein PC-1 primary structure deduced from cDNA clones
-
van Driel I.R., Goding J.W. Plasma cell membrane glycoprotein PC-1 primary structure deduced from cDNA clones. J. Biol. Chem. 262:1987;4882-4887.
-
(1987)
J. Biol. Chem.
, vol.262
, pp. 4882-4887
-
-
Van Driel, I.R.1
Goding, J.W.2
-
20
-
-
0029153730
-
Inhibition of insulin receptor phosphorylation by PC-1 is not mediated by the hydrolysis of adenosine triphosphate or the generation of adenosine
-
Grupe A., Alleman J., Goldfine I.D., Sadick M., Stewart T.A. Inhibition of insulin receptor phosphorylation by PC-1 is not mediated by the hydrolysis of adenosine triphosphate or the generation of adenosine. J. Biol. Chem. 38:1995;22085-22088.
-
(1995)
J. Biol. Chem.
, vol.38
, pp. 22085-22088
-
-
Grupe, A.1
Alleman, J.2
Goldfine, I.D.3
Sadick, M.4
Stewart, T.A.5
|